MERCOSUR: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in MERCOSUR

The MERCOSUR prophylactic medicaments containing insulin market fell slightly to $X in 2022, shrinking by -2.8% against the previous year. The market value increased at an average annual rate of +2.2% over the period from 2012 to 2022; however, the trend pattern remained consistent, with only minor fluctuations throughout the analyzed period. Over the period under review, the market hit record highs at $X in 2019; however, from 2020 to 2022, consumption stood at a somewhat lower figure.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in MERCOSUR

In value terms, prophylactic medicaments containing insulin production dropped modestly to $X in 2022 estimated in export price. The total output value increased at an average annual rate of +1.9% from 2012 to 2022; however, the trend pattern remained consistent, with somewhat noticeable fluctuations in certain years. The pace of growth appeared the most rapid in 2013 with an increase of 13%. Over the period under review, production attained the peak level at $X in 2019; however, from 2020 to 2022, production remained at a lower figure.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports in MERCOSUR

In 2022, the amount of medicaments containing insulin but not antibiotics in measured doses exported in MERCOSUR soared to X tons, jumping by 20% on 2021. In general, exports, however, saw a abrupt contraction. The growth pace was the most rapid in 2013 when exports increased by 44% against the previous year. The volume of export peaked at X tons in 2014; however, from 2015 to 2022, the exports remained at a lower figure.

In value terms, prophylactic medicaments containing insulin exports soared to $X in 2022. Overall, exports, however, faced a deep contraction. Over the period under review, the exports hit record highs at $X in 2013; however, from 2014 to 2022, the exports stood at a somewhat lower figure.

Exports by Country

Brazil (X tons) represented roughly 100% of total exports in 2022.

Brazil was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics in measured doses exports, with a CAGR of -8.4% from 2012 to 2022. The shares of the largest exporters remained relatively stable throughout the analyzed period.

In value terms, Brazil ($X) also remains the largest prophylactic medicaments containing insulin supplier in MERCOSUR.

From 2012 to 2022, the average annual growth rate of value in Brazil amounted to -15.8%.

Export Prices by Country

In 2022, the export price in MERCOSUR amounted to $X per ton, growing by 35% against the previous year. Overall, the export price, however, continues to indicate a abrupt downturn. The level of export peaked at $X per ton in 2012; however, from 2013 to 2022, the export prices remained at a lower figure.

As there is only one major export destination, the average price level is determined by prices for Brazil.

From 2012 to 2022, the rate of growth in terms of prices for Brazil amounted to -8.1% per year.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports in MERCOSUR

In 2022, imports of medicaments containing insulin but not antibiotics in measured doses in MERCOSUR dropped to X tons, which is down by -8.6% compared with 2021. Total imports indicated a buoyant increase from 2012 to 2022: its volume increased at an average annual rate of +5.7% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, imports increased by +77.1% against 2013 indices. The most prominent rate of growth was recorded in 2014 with an increase of 37% against the previous year. Over the period under review, imports reached the peak figure at X tons in 2021, and then reduced in the following year.

In value terms, prophylactic medicaments containing insulin imports amounted to $X in 2022. Over the period under review, imports, however, showed a relatively flat trend pattern. The growth pace was the most rapid in 2014 with an increase of 30% against the previous year. As a result, imports reached the peak of $X. From 2015 to 2022, the growth of imports remained at a lower figure.

Imports by Country

In 2022, Colombia (X tons), distantly followed by Brazil (X tons), Argentina (X tons) and Chile (X tons) represented the main importers of medicaments containing insulin but not antibiotics in measured doses, together achieving 91% of total imports. Ecuador (X tons), Paraguay (X tons) and Peru (X tons) followed a long way behind the leaders.

From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the main importing countries, was attained by Ecuador (with a CAGR of +29.2%), while imports for the other leaders experienced more modest paces of growth.

In value terms, Colombia ($X), Chile ($X) and Brazil ($X) constituted the countries with the highest levels of imports in 2022, with a combined 66% share of total imports. Argentina, Paraguay, Ecuador and Peru lagged somewhat behind, together accounting for a further 31%.

In terms of the main importing countries, Ecuador, with a CAGR of +25.1%, saw the highest growth rate of the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The import price in MERCOSUR stood at $X per ton in 2022, picking up by 12% against the previous year. Over the period under review, the import price, however, showed a perceptible contraction. The level of import peaked at $X per ton in 2013; however, from 2014 to 2022, import prices stood at a somewhat lower figure.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was Peru ($X per ton), while Brazil ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Paraguay (+1.4%), while the other leaders experienced mixed trends in the import price figures.

Source: IndexBox Platform